Today in News History

On July 12, several notable moments in the history of News stand out. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1928, Alastair Burnet, English journalist (died 2012) was born. In 1931, Nathan Söderblom, Swedish archbishop, Nobel Prize laureate (born 1866) passed away. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 1970, Susan Tyler Witten, American politician was born. In 1986, JP Pietersen, South African rugby player was born. In 1988, Patrick Beverley, American basketball player was born. In 1997, Malala Yousafzai, Pakistani-English activist, Nobel Prize laureate was born. In 2001, Space Shuttle program: Space Shuttle Atlantis is launched on mission STS-104, carrying the Quest Joint Airlock to the International Space Station. In 2008, Bobby Murcer, American baseball player, coach, and sportscaster (born 1946) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Phages could enable us to hijack vaccine immunity to kill cancer cells

New Scientist

New Scientist

·

June 25, 2026

·

center
Phages could enable us to hijack vaccine immunity to kill cancer cells

Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines

Narrative Intelligence Brief

This article was published by New Scientist, a source frequently categorized with a center bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of New Scientist, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 17%

Center 83%

Right 0%


The Eastern Herald

center

· Jul 2, 2026

An Immune Cell Meant to Fight Cancer Gets Reprogrammed by Tumors to Help Them Instead

Tel Aviv University researchers found that macrophages, the immune cells that clear dead cancer cells, get reprogrammed to stimulate tumor blood vessel growth instead of fighting cancer. The Effero-seq technology used to track this process in real time may point toward a new class of therapeutic targets.

New Scientist

center

· Jun 25, 2026

Bacteria-killing viruses redirect vaccine immunity to destroy cancer

Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines

Medical Daily

center

· Jul 10, 2026

Scientists Discovered a Hidden Immune Backup System That Could Make mRNA Cancer Vaccines Far More Powerful

Washington University researchers found mRNA cancer vaccines activate an unexpected backup immune pathway. The Nature study could help improve vaccines for melanoma, lung cancer, and more.

Science Daily

center

· Jun 25, 2026

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.

Portside

left

· Jun 22, 2026

Sunday Science: Killing Cancer Requires Immune Cells To Infiltrate Tumors’ Hostile Microenvironment – Sugar Shields Can Help Them Break In

Sunday Science: Killing Cancer Requires Immune Cells To Infiltrate Tumors’ Hostile Microenvironment – Sugar Shields Can Help Them Break In Ira Mon, 06/22/2026 - 03:25

KTLA 5

center

· Jul 9, 2026

New research finds this popular muscle-building supplement helps fight cancer

New UCLA research reveals creatine, a popular muscle-building supplement, also enhances the immune system's killer T cells, potentially strengthening the body's fight against cancer. Subscribe: https://www.youtube.com/ktla?sub_confirmation=1

Topics:

World · 2
Science · 2
Health · 1
Unknown · 1

Related coverage for "Phages could enable us to hijack vaccine immunity to kill cancer cells": The Eastern Herald — An Immune Cell Meant to Fight Cancer Gets Reprogrammed by Tumors to Help Them Instead. New Scientist — Bacteria-killing viruses redirect vaccine immunity to destroy cancer. Medical Daily — Scientists Discovered a Hidden Immune Backup System That Could Make mRNA Cancer Vaccines Far More Powerful. Science Daily — FDA-approved drug may finally help immunotherapy defeat rare liver cancer. Portside — Sunday Science: Killing Cancer Requires Immune Cells To Infiltrate Tumors’ Hostile Microenvironment – Sugar Shields Can Help Them Break In. KTLA 5 — New research finds this popular muscle-building supplement helps fight cancer